Figure 2.
Mean (SD) of posaconazole plasma concentration–time profiles by disease state (day 1 and day 8) following multiple dosing of a 300 mg posaconazole tablet formulation once daily (serial PK-evaluable population).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.